Disc Medicine Announces $62.5 Million Financing Led By Bain Capital Life Sciences To Advance Portfolio Of Novel Hematology Programs
Amount Raised
$62.5 Million
Round Type
Funding Round
WatertownBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Disc Medicine, Inc. (NASDAQ: IRON) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it has entered into a securities purchase agreement with certain investors resulting in an aggregate $62.5 million in gross proceeds through a registered direct offering. The financing was led by Bain Capital Life Sciences, who contributed $50 million, with participation from existing investors, Access Biotechnology and OrbiMed.
Quick answer
Disc raised $62.5 Million in a Funding Round round, dated February 14, 2023. Disc is based in Watertown, Massachusetts, United States.
- How much did Disc raise?
- Disc raised $62.5 Million in a Funding Round round on February 14, 2023.
- What does Disc do?
- Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.
- Where is Disc based and how big is it?
- Disc is based in Watertown, Massachusetts, United States. Fundz records about 174 employees.
- Who are the decision-makers at Disc?
- Fundz holds 1 contact at Disc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Disc that raised within 45 days of this round, from Fundz verified event records.
- Milestone Pharmaceuticals raised $125M on March 28, 2023.
- Provention Bio raised $35M on February 13, 2023.
- CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
- HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
- OnKure Therapeutics raised $57M on March 24, 2023.
- Entero Therapeutics raised $4M (Seed) on March 15, 2023.
Who to call at Disc, and when
A new round usually means Disc is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Disc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Disc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Disc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Disc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Disc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.